News

DLBCL accounts for about 25% of all NHLs in the developed world and it occurs primarily in older individuals, while the disease can also occur in children and

The pancreatic cancer treatment includes implanting living cells that have been encapsulated in pin-head sized, cellulose-based, protective cocoons through the use of the Cell-in-a-Box technology, followed by the

Conducted in 35 centres in Korea, Taiwan, Hong Kong and India, the trial is designed to assess the safety and efficacy of intravenous Brinavess in patients with recent-onset

AVP-825 is a drug-device combination product consisting of low-dose sumatriptan powder, delivered intranasally utilizing a novel Breath Powered delivery technology. The FDA has raised questions regarding the human

The transaction, subject to regulatory approval and other customary closing conditions, is expected to close by the first quarter of 2015. Over the past seven years, KU has

Results were presented in a poster presentation entitled "Novel synthetic RORgamma agonist compounds as a potential anti-tumor therapeutic approach" and will be highlighted in an oral presentation on

As part of this collaboration, Idera and PPMD intend to work together to conduct preclinical studies and develop a clinical development strategy for an investigational TLR antagonist candidate.

ORSL is a fruit-based drink useful for electrolytes restoration during mild dehydration and general disability. It is generally used following cough & cold, pain, fever and other digestive

The trial showed that these patients with the most common type of EGFR mutation, (exon 19 deletion; del19), lived significantly longer after receiving first-line treatment with afatinib compared